Joint Care Ultra
Natural health product licensed in Canada
- Other names
- Joint Care Advanced, Joint Pain Ultra, Triple Action Joint Care, Triple Action Joint Pain
- Licence holder
- HPI Health Products Inc.
- NPN or DIN-HM
- 80130343
- Status
- Active licence
- Licence date
- 2 April 2024
- Revision date
- 9 September 2024
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Sélénium Source : Selenium amino acid chelate | 13 microgram | 39 µg |
| Cuivre Source : Chélate d'acide aminé de cuivre | 350 microgram | 1,050 µg |
| Acide pantothénique Source : D-Pantothénate de calcium | 5 mg | 15,000 µg |
| Manganèse Source : Produit de chélation de manganèse et d'acide aminé | 0.75 mg | 2,250 µg |
| Curcuma longa Source : Curcuma longa - rhizome Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 1,400 mg | 140 mg | Not calculated |
| Boswellia serrata Source : Boswellia serrata - Oléo-gomme-résine (écorce de tige) Potency : 40 % Boswellic acids | 333 mg | Not calculated |
| Acide hyaluronique Source : Streptococcus equi - capsule extracellulaire bactérienne | 48 mg | Not calculated |
| Acide hyaluronique Source : Hyaluronate de sodium | 48 mg | Not calculated |
| 1-[(2E, 4E)-5-(1,3-Benzodioxole-5-yl)-1-oxo-2,4-pentadiényl] pipéridine Source : Piper nigrum - fruit | 3.5 mg | Not calculated |
| Collagène hydrolysé | 20 mg | Not calculated |
| Vitamine C Source : Acide ascorbique | 6 mg | 18,000 µg |
| Curcuma longa Source : Curcuma longa - rhizome Potency : 50 % Curcuminoids | 45 mg | Not calculated |
Non-medicinal ingredients
Gélatine, Stéarate de magnésium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 1 Capsule | 3 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Used in Herbal Medicine as an anti-inflammatory to help relieve joint pain. Helps in collagen formation to maintain/support healthy bones. Helps in the development and maintenance of bones. Helps support joint health. Helps to relieve joint pain and swelling associated with osteoarthritis of the knee. Helps in energy metabolism/(and) tissue formation. Helps normal growth and development. Helps to form red blood cells. Helps to maintain/support normal function of the thyroid gland Helps to maintain/support normal iron transport in the body. Helps to maintain/support the body¿s ability to metabolize nutrients. Helps to prevent pantothenic acid deficiency. Helps to produce and repair connective tissue. Source of/Provides (an) antioxidant(s) for the maintenance of good health. Source of/Provides (an) antioxidant(s) that help(s) fight/protect (cell) against/reduce (the oxidative effect of/the oxidative damage caused by/cell damage caused by) free radicals. Source of/Provides an antioxidant that helps protect against oxidative stress.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80130343
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2024. Photograph the packaging to check whether it has changed. Photograph the packaging